French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taipei rally voices migrant workers' anger over work-year limit
12/07/2025 09:34 PM - Society
U.S. vaccine rollback 'regressive,' requires Taiwan vigilance: Expert
12/07/2025 09:15 PM - Society
Firefighters extinguish blaze at Sanxia chemical factory
12/07/2025 09:13 PM - Society
Man arrested for ax attack against police officer detained
12/07/2025 09:02 PM - Business
For TSMC employees in Phoenix, Taiwan Mama delivering taste of home
12/07/2025 06:51 PM